泌尿器科領域におけるCefsulodiin (SCE-129) の検討
1979 年 27 巻 Supplement2 号 p. 289-294
詳細
1979 年 27 巻 Supplement2 号 p. 289-294
Laboratory and clinical studies on Cefsulodin (SCE-129, CFS) were performed and the following results were obtained.
1. CFS showed a peak MIC of 3.13μg/ml on susceptibility against 27 strains of clinically isolated P. aeruginosa.
2. CFS was given to six patients with chronic complicated urinary tract infections. The therapeutic effects were excellent in one patient, good in 2 patients and poor in 3 patients.
3. No side effect was seen except slight elevations of GOT and GPT in a patient with the complications of bilateral hydronephrosis and invasion of prostatic cancer to vesical wall.
